299 related articles for article (PubMed ID: 36569931)
1. How GRAIL controls Treg function to maintain self-tolerance.
Fathman CG; Yip L; Gómez-Martín D; Yu M; Seroogy CM; Hurt CR; Lin JT; Jenks JA; Nadeau KC; Soares L
Front Immunol; 2022; 13():1046631. PubMed ID: 36569931
[TBL] [Abstract][Full Text] [Related]
2. A Common Druggable Defect in Regulatory T Cells from Patients with Autoimmunity.
Soares L; Yip L; Hurt CR; Fathman G
Crit Rev Immunol; 2020; 40(3):185-193. PubMed ID: 33389883
[TBL] [Abstract][Full Text] [Related]
3. Low-dose IL-2 therapy in autoimmune diseases: An update review.
Zhang R; Zhao Y; Chen X; Zhuang Z; Li X; Shen E
Int Rev Immunol; 2024 May; 43(3):113-137. PubMed ID: 37882232
[TBL] [Abstract][Full Text] [Related]
4. T Regulatory Cells From Non-obese Diabetic Mice Show Low Responsiveness to IL-2 Stimulation and Exhibit Differential Expression of Anergy-Related and Ubiquitination Factors.
Godoy GJ; Olivera C; Paira DA; Salazar FC; Ana Y; Stempin CC; Motrich RD; Rivero VE
Front Immunol; 2019; 10():2665. PubMed ID: 31824482
[TBL] [Abstract][Full Text] [Related]
5. PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg development.
Sharabi A; Li H; Kasper IR; Pan W; Meidan E; Tsokos MG; Moulton VR; Tsokos GC
JCI Insight; 2019 Mar; 5(9):. PubMed ID: 30912768
[TBL] [Abstract][Full Text] [Related]
6. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
[TBL] [Abstract][Full Text] [Related]
7. Naive CD4 t cell proliferation is controlled by mammalian target of rapamycin regulation of GRAIL expression.
Lin JT; Lineberry NB; Kattah MG; Su LL; Utz PJ; Fathman CG; Wu L
J Immunol; 2009 May; 182(10):5919-28. PubMed ID: 19414743
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of IL-12 on Tregs and non-Treg T cells: roles of IFN-γ, IL-2 and IL-2R.
Zhao J; Zhao J; Perlman S
PLoS One; 2012; 7(9):e46241. PubMed ID: 23029447
[TBL] [Abstract][Full Text] [Related]
9. Treg Enhancing Therapies to Treat Autoimmune Diseases.
Eggenhuizen PJ; Ng BH; Ooi JD
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
[TBL] [Abstract][Full Text] [Related]
10. Acute Lipopolysaccharide-Induced Inflammation Lowers IL-2R Signaling and the Proliferative Potential of Regulatory T Cells.
Hsiung S; Moro A; Ban Y; Chen X; Savio AS; Hernandez R; Malek TR
Immunohorizons; 2020 Dec; 4(12):809-824. PubMed ID: 33334814
[TBL] [Abstract][Full Text] [Related]
11. IL-2 as a therapeutic target for the restoration of Foxp3+ regulatory T cell function in organ-specific autoimmunity: implications in pathophysiology and translation to human disease.
d'Hennezel E; Kornete M; Piccirillo CA
J Transl Med; 2010 Nov; 8():113. PubMed ID: 21059266
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulation Followed by Antigen-Specific T
Cabello-Kindelan C; Mackey S; Sands A; Rodriguez J; Vazquez C; Pugliese A; Bayer AL
Diabetes; 2020 Feb; 69(2):215-227. PubMed ID: 31712320
[TBL] [Abstract][Full Text] [Related]
13. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
14. Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins.
Ghelani A; Bates D; Conner K; Wu MZ; Lu J; Hu YL; Li CM; Chaudhry A; Sohn SJ
Front Immunol; 2020; 11():1106. PubMed ID: 32582190
[TBL] [Abstract][Full Text] [Related]
15. Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination
DeOca KB; Moorman CD; Garcia BL; Mannie MD
Front Immunol; 2020; 11():541619. PubMed ID: 33072087
[TBL] [Abstract][Full Text] [Related]
16. Splicing factor SRSF1 controls autoimmune-related molecular pathways in regulatory T cells distinct from FoxP3.
Cassidy MF; Herbert ZT; Moulton VR
Mol Immunol; 2022 Dec; 152():140-152. PubMed ID: 36368121
[TBL] [Abstract][Full Text] [Related]
17. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.
Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA
PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757
[TBL] [Abstract][Full Text] [Related]
18. IL-2R signaling is essential for functional maturation of regulatory T cells during thymic development.
Cheng G; Yu A; Dee MJ; Malek TR
J Immunol; 2013 Feb; 190(4):1567-75. PubMed ID: 23315074
[TBL] [Abstract][Full Text] [Related]
19. Treg Therapies Revisited: Tolerance Beyond Deletion.
Pilat N; Sprent J
Front Immunol; 2020; 11():622810. PubMed ID: 33633742
[TBL] [Abstract][Full Text] [Related]
20. CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells.
Ding Y; Yu A; Tsokos GC; Malek TR
J Immunol; 2019 Jul; 203(1):93-104. PubMed ID: 31085588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
